EyePoint Pharmaceuticals EYPT
$ 8.94
7.07%
Quarterly report 2024-Q3
added 11-07-2024
EyePoint Pharmaceuticals ROCE Ratio 2011-2024 | EYPT
Annual ROCE Ratio EyePoint Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-28.19 | -103.39 | -29.98 | -48.54 | -77.88 | -52.54 | -138.76 | -82.09 | 22.13 | -66.04 | -92.93 | -59.6 | -23.77 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
22.13 | -138.76 | -60.12 |
Quarterly ROCE Ratio EyePoint Pharmaceuticals
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-79.23 | -104.0 | -91.81 | -105.3 | -94.23 | -67.18 | -37.15 | -53.66 | -56.68 | -54.25 | -36.23 | -46.79 | -40.83 | -90.71 | -132.43 | -240.29 | -398.52 | -460.4 | -574.56 | -495.94 | -363.17 | -267.13 | -127.27 | -156.66 | -187.37 | -220.02 | -250.73 | -192.73 | -176.16 | -118.16 | -101.17 | -136.85 | -113.17 | -148.84 | -125.59 | -102.02 | -17.48 | 6.08 | 171.86 | 156.51 | 72.33 | 39.09 | -148.49 | -139.56 | -129.47 | -102.9 | -73.61 | -153.59 | -144.75 | -172.47 | -160.23 | -7.18 | -47.13 | -6.76 |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
171.86 | -574.56 | -127.87 |